Slovak
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
carbohydrate/zápal
Odkaz sa uloží do schránky
Strana 1 od 60 výsledky
Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention is directed to methods for inhibiting immune responses or cellular interactions in mammals by the administration thereto of one or more lectin derived carbohydrate binding peptides. In particular, this invention is directed to
Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding peptides
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention is directed to methods for inhibiting immune responses or cellular interactions in mammals by the administration thereto of one or more lectin derived carbohydrate binding peptides. In particular, this invention is directed to
Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention is directed to methods for inhibiting immune responses or cellular interactions in mammals by the administration thereto of one or more lectin derived carbohydrate binding peptides. In particular, this invention is directed to
Pro-gut maturation and anti-inflammatory effects of lactobacillus and lactobacillus secreted proteins, carbohydrates and lipids
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to Lactobacillus secreted proteins, carbohydrates and lipids and other anaerobic bacterial strains known to exert effects similar to Lactobacillus strains and their use in the prevention and treatment of
Carbohydrate-based anti-inflammatory agents
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
FIELD OF THE INVENTION
This invention relates generally to determining the presence of and relieving the effects of inflammation. More specifically, this invention relates to carbohydrate ligands which bind to endothelial leukocyte adhesion molecule-1 (hereinafter ELAM-1) and to compositions
Peptide T and related peptides in the treatment of inflammation, including inflammatory bowel disease
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
This application is a 371 of PCT/GB93/00649, filed Mar. 29, 1993.
The present invention relates, broadly, to the treatment of prevention of inflammation, whether caused by bacteria, viruses and/or other infective agents, opportunistic infections (which may be consequent on an immunodepressed state,
Peptide T and related peptides in the treatment of inflammation, including multiple sclerosis
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
The present invention relates, broadly to the treatment or prevention of inflammation, whether caused by bacteria, viruses and/or other infective agents, opportunistic infections (which may be consequent on an immunodepressed state, for example resulting from cancer or therapy, particularly
Anti-flammatory carbohydrate binding-peptides
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention is directed to methods for inhibiting immune responses or cellular interactions in mammals by the administration thereto of one or more lectin derived carbohydrate binding peptides. In particular, this invention is directed to
Inhibition of cell adhesion protein-carbohydrate interactions
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
BACKGROUND OF THE INVENTION
This invention relates to therapeutic interference with interactions between cell adhesion proteins and their carbohydrate ligands.
ELAM-1 is an integral membrane adhesion protein. It possesses an extracellular domain including an N-terminal lectin-related segment, an
Inhibition of cell adhesion protein-carbohydrate interactions
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
BACKGROUND OF THE INVENTION
This invention relates to therapeutic interference with interactions between cell adhesion proteins and their carbohydrate ligands.
ELAM-1 is an integral membrane adhesion protein. It possesses an extracellular domain including an N-terminal lectin-related segment, an
Nucleic acid encoding an antibody that inhibits cell adhesion protein-carbohydrate interactions
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
BACKGROUND OF THE INVENTION
This invention relates to therapeutic interference with interactions between cell adhesion proteins and their carbohydrate ligands.
ELAM-1 is an integral membrane adhesion protein. It possesses an extracellular domain including an N-terminal lectin-related segment, an
Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
BACKGROUND AND FIELD OF THE INVENTION
Complex carbohydrates, for purposes of this invention are defined as any polymer comprising more than two sugar moieties and would thus include such classes of compounds as polysaccharides and oligosaccharides. Polysaccharides include glycosaminoglycans and
Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
BACKGROUND AND FIELD OF THE INVENTION
Complex carbohydrates, for purposes of this invention are defined as any polymer comprising more than two sugar moieties and would thus include such classes of and oliosaccharides. Polysaccharides include glycosaminoglycans and mannans whereas oligosaccharides
Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
BACKGROUND AND FIELD OF THE INVENTION
The invention relates to a method of preventing and treating diseases and conditions of mammals associated with the adhesion, metastatic and coronary cascades comprising applying a composition of complex carbohydrates and essential oils topically, orally or
Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
BACKGROUND AND FIELD OF THE INVENTION
The invention relates to a method of preventing and treating diseases and conditions of mammals associated with the adhesion, metastatic and coronary cascades comprising applying a composition of complex carbohydrates and essential oils topically, orally or
Najkompletnejšia databáza liečivých bylín podporovaná vedou
- Pracuje v 55 jazykoch
- Bylinné lieky podporené vedou
- Rozpoznávanie bylín podľa obrázka
- Interaktívna GPS mapa - označte byliny na mieste (už čoskoro)
- Prečítajte si vedecké publikácie týkajúce sa vášho hľadania
- Vyhľadajte liečivé byliny podľa ich účinkov
- Usporiadajte svoje záujmy a držte krok s novinkami, klinickými skúškami a patentmi
Zadajte príznak alebo chorobu a prečítajte si o bylinách, ktoré by vám mohli pomôcť, napíšte bylinu a pozrite sa na choroby a príznaky, proti ktorým sa používa.
* Všetky informácie sú založené na publikovanom vedeckom výskume
